| {"0": "Degradation pathway of sphingolipids including diseases", "1": "Glycosaminoglycan degradation", "2": "Striated muscle contraction pathway", "3": "Mapk cascade", "4": "Nanoparticlemediated activation of receptor signaling", "5": "Serotonin htr1 group and fos pathway", "6": "Aryl hydrocarbon receptor pathway wp2586", "7": "Synaptic signaling pathways associated with autism spectrum disorder", "8": "Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement", "9": "Nrp1triggered signaling pathways in pancreatic cancer", "10": "Regulatory circuits of the stat3 signaling pathway", "11": "Embryonic stem cell pluripotency pathways", "12": "S1p receptor signal transduction", "13": "Photodynamic therapyinduced ap1 survival signaling", "14": "Egfr tyrosine kinase inhibitor resistance", "15": "Glycogen synthesis and degradation", "16": "Il6 signaling pathway", "17": "Nonsmall cell lung cancer", "18": "Melanoma", "19": "Follicle stimulating hormone fsh signaling pathway", "20": "Mirna regulation of prostate cancer signaling pathways", "21": "Corticotropinreleasing hormone signaling pathway", "22": "Arrhythmogenic right ventricular cardiomyopathy", "23": "Apoptosisrelated network due to altered notch3 in ovarian cancer", "24": "Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms", "25": "4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression", "26": "Alpha 6 beta 4 signaling pathway", "27": "Thymic stromal lymphopoietin tslp signaling pathway", "28": "Oncostatin m signaling pathway", "29": "Glioblastoma signaling pathways", "30": "Resistin as a regulator of inflammation", "31": "Mesodermal commitment pathway", "32": "Netrinunc5b signaling pathway", "33": "Tcell activation sarscov2", "34": "Cardiac hypertrophic response", "35": "Met in type 1 papillary renal cell carcinoma", "36": "Spinal cord injury", "37": "G1 to s cell cycle control", "38": "Head and neck squamous cell carcinoma", "39": "Tnfrelated weak inducer of apoptosis tweak signaling pathway", "40": "Fluoropyrimidine activity", "41": "Wnt signaling pathway and pluripotency", "42": "Dna damage response only atm dependent", "43": "Physicochemical features and toxicityassociated pathways", "44": "Il2 signaling pathway", "45": "Endoderm differentiation", "46": "Primary focal segmental glomerulosclerosis fsgs", "47": "Chromosomal and microsatellite instability in colorectal cancer", "48": "Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells", "49": "Translation inhibitors in chronically activated pdgfra cells"} |